AI assistant
ANGIODYNAMICS INC — Director's Dealing 2021
Oct 6, 2021
32939_dirs_2021-10-06_05bd7802-1cc1-4de9-af61-f54e94b251a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2021-10-05
Reporting Person: Campbell Chad Thomas (SVP/GM, Vascular Access)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-05 | Common Stock | M | 10748 | $16.59 | Acquired | 42489 | Direct |
| 2021-10-05 | Common Stock | S | 10748 | $27.15 | Disposed | 31741 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-05 | Non-Qualified Stock Option (right to buy) | $16.59 | M | 10748 | Disposed | 2023-07-25 | Common Stock (10748) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.07 to $27.35, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
F2: Options for one-fourth of the shares became exercisable on 7/27/2017, 7/27/2018, 7/27/2019 and 7/27/2020, respectively.